Joel A. Cummings
Joel A. Cummings publishes mostly in Physiology, Molecular Biology and Cell Biology, on topics such as Alzheimer's disease research and treatments, Proteoglycans and glycosaminoglycans research and Glycosylation and Glycoproteins Research.
- World rank
- #3,446,061 of 7,710,434 ranked researchers
- Rank in United States
- #966,761 of 1,627,098
- Works
- 27
- Citations
- 666
- Citations per work
- 24.7
What does Joel A. Cummings research?
Joel A. Cummings's work is mostly in Medicine (37%), Biochemistry, Genetics and Molecular Biology (35%), Pharmacology, Toxicology and Pharmaceutics (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1140.0%
- Health Sciences1036.9%
- Medicine1036.9%
- Everything else518.5%
- Physical Sciences14.6%
- Chemistry14.6%
- 1Physiology29% of their works
- 2Molecular Biology26% of their works
- 3Cell Biology9% of their works
- 4Pharmacology8% of their works
- 5Organic Chemistry5% of their works
- 6Pharmacology5% of their works
Research topics
- Alzheimer's disease research and treatments
- Proteoglycans and glycosaminoglycans research
- Glycosylation and Glycoproteins Research
- Cholinesterase and Neurodegenerative Diseases
- 14-3-3 protein interactions
- Alkaloids: synthesis and pharmacology
- Cancer therapeutics and mechanisms
- Biological Research and Disease Studies
Which keywords describe Joel A. Cummings's research?
The keywords of their largest research topics: Amyloid Hypothesis, Tau Pathology, Cell Signaling, Toxicology, Alzheimer's Disease, Cancer, Acetylcholinesterase and Cholinesterase Inhibitors.
- Topoisomerases
- Phosphoethanolamine
- cancer development
- Alkaloids
- Proteoglycans
- Glycosylation
- Cholinesterase Inhibitors
- Cancer
- Toxicology
- Tau Pathology
- Amyloid Hypothesis
- Cell Signaling
- Alzheimer's Disease
- Acetylcholinesterase
- Glycans
- Hyaluronan
- 14-3-3 Proteins
- Kratom
- DNA
- Synthetic
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Amyloid Hypothesis181 topic
- Tau Pathology181 topic
- Cell Signaling82 topics
- Toxicology82 topics
- Alzheimer's Disease72 topics
- Cancer72 topics
- Acetylcholinesterase51 topic
- Cholinesterase Inhibitors51 topic
- Glycans51 topic
- Glycosylation51 topic
- Hyaluronan51 topic
- Proteoglycans51 topic
- 14-3-3 Proteins31 topic
- Alkaloids31 topic
- Kratom31 topic
- cancer development31 topic
- DNA21 topic
- Phosphoethanolamine21 topic
- Synthetic21 topic
- Topoisomerases21 topic
Where does Joel A. Cummings work?
Joel A. Cummings's main affiliation in the publication record is ProteoTech (United States), United States.
How many publications and citations does Joel A. Cummings have?
OpenAlex counts 27 works and 666 citations for Joel A. Cummings, an h-index of 9, ranking #3,446,061 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Joel A. Cummings. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.